KNSA

KINIKSA PHARMACEUTICALS INTL

KNSA·G52694109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

KNSA (KINIKSA PHARMACEUTICALS INTL) is held by 147 institutional investors as of Q2 2026. Largest holders: FMR LLC ($445.8M), BAKER BROS. ADVISORS LP ($181.3M), BlackRock, Inc. ($175.2M). Net institutional sentiment: Mixed.

147
Holders
(13 Elite)
$2.1B
Total Value
60% (148)
Consensus
89 buying - 59 selling
13F: Insider & Congress: Updated regularly
KNSA

Smart Money Verdict

View all
Loading verdict
Held by 147 funds
13 elite

Who's Trading

Source dates: Price Oct 9, 2026 · Insiders Sep 3, 2026 · Activists Jul 29, 2026 · Congress none

InsiderMRMegna Michael RSell $369KSep 3, 2026
InsiderPKPatel Sanj KTax 15K shSep 1, 2026
InsiderPKPatel Sanj KTax 15K shSep 1, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
7M(+2.2%)$445.8M0.0%+79.55%
32
Increased
2.8M(+0.3%)$181.3M0.9%+323.53%
43
Increased
2.7M(+462.9%)$175.2M0.0%+41.16%
49
Increased
1.9M(+8.2%)$122.2M0.0%+61.66%
33
Increased
1.4M(+2.1%)$87M0.0%+64.59%
30
Increased
1M(+1.3%)$64.7M0.0%+234.31%
30
Increased
957,514(+7.3%)$61.2M0.0%+139.09%
32
Increased
874,786(+7.7%)$55.9M0.0%+184.18%
32
Increased
772,806(+2694.3%)$49.4M0.0%+27.20%
47
Increased
718,199(+17.5%)$45.9M0.3%+197.72%
41
Increased
704,194(+818.9%)$45M0.0%+34.68%
47
Increased
659,493(+2.9%)$42.2M0.0%+177.72%
30
Decreased
608,650(-2.4%)$38.9M0.0%+327.32%
0
Increased
604,180(+1263.2%)$38.6M0.0%+31.55%
47
First report
586,177$37.5M0.0%—
0
Decreased
572,598(-11.9%)$36.6M0.1%+209.32%
0
Decreased
569,756(-40.6%)$36.4M0.0%+165.64%
0
Increased
561,480(+33.4%)$35.9M0.0%+86.53%
37
Decreased
504,853(-0.3%)$32.3M0.0%+93.41%
0
Decreased
437,192(-32.5%)$28M0.0%+148.23%
0

Showing 1-20 of 157

1 / 8
KNSAKNSAKINIKSA PHARMACEUTICALS INTL

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used